Analgesics in France

Product Code EUR00646
Publication Date May 2011
Publisher Euromonitor
Product Type Report
Pages 41
ISBN Number not applicable
Change currency
PDF £600.00 €723 $949 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Analgesics in France

Consumers continued to be very confident in terms of self-medication with analgesics to relieve pain. However, there remained a lack of investment within the aspirin category, which partly explains the modest performance of analgesics in 2010. Aspirin continued to be threatened by consumers' preference for acetaminophen and ibuprofen.

Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

  • Analgesics in France
  • Euromonitor International
  • May 2011
  • List of Contents and Headlines
    • Trends
    • Switches
    • Competitive Landscape
    • Prospects
    • Category Data
    • Bayer Sante Familiale Sas in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 1 Bayer Santé Familiale SAS: Key Facts
  • Summary 2 Bayer Santé Familiale SAS: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 3 Bayer Santé Familiale: Competitive Position 2010
    • Cooperation Pharmaceutique Francaise Sas (cooper) in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 4 Cooperation Pharmaceutique Francaise SAS (Cooper): Key Facts
  • Summary 5 Cooperation Pharmaceutique Francaise SAS (Cooper): Operational Indicators
    • Company Background
    • Production
  • Summary 6 Cooperation Pharmaceutique Francaise SAS (Cooper): Production Statistics 2010
    • Competitive Positioning
  • Summary 7 Cooperation Pharmaceutique Francaise SAS (Cooper): Competitive Position 2010
    • Laboratoires Mcneil in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 8 Laboratoires McNeil: Key Facts
  • Summary 9 Laboratoires McNeil: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 10 Laboratoires McNeil: Competitive Position 2010
    • Pierre Fabre Sa, Laboratoires in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 11 Laboratoires Pierre Fabre SA: Key Facts
  • Summary 12 Laboratoires Pierre Fabre SA: Operational Indicators
    • Company Background
    • Production
  • Summary 13 Laboratoires Pierre Fabre SA: Production Statistics 2010
    • Competitive Positioning
  • Summary 14 Laboratoires Pierre Fabre SA: Competitive Position 2010
    • Théraplix SA in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 15 Théraplix SA: Key Facts
    • Company Background
    • Competitive Positioning
  • Summary 16 Théraplix SA: Competitive Position 2010
    • Urgo, Laboratoires in Consumer Health (france)
    • Strategic Direction
    • Key Facts
  • Summary 17 Laboratoires Urgo: Key Facts
  • Summary 18 Laboratoires Urgo: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 19 Laboratoires Urgo: Competitive Position 2010
    • Executive Summary
    • Consumer Health Sees Modest, But Faster, Growth in Comparison With 2009
    • 2010 Is A Year Full of Important Events
    • New OTC Proton Pump Inhibitors Behind Best Value Share Performances
    • Chemists/pharmacies Continues To Be the Main Distribution Channel
    • Low Overall Performances for the Forecast Period
    • Key Trends and Developments
    • Switches Driving Sales Growth
    • Ageing Population A Key Driver for Consumer Health
    • Further Increases in Tobacco Prices Responsible for New Growth of Nrt Smoking Cessation Aids
    • Tightened Legislation Concerning Dietary Supplements Expected for 2011
    • Further Competition Expected at Retailing Level
    • Market Indicators
    • Market Data
    • OTC Registration and Classification
    • Advertising
    • Packaging and Labelling
    • Distribution
    • Vitamins and Dietary Supplements Registration and Classification
    • EU Legislation
    • Self-medication/self-care and Preventive Medicine
    • Generics
    • Switches
  • Summary 20 OTC Healthcare Switches 2008-2010
    • Definitions
  • Summary 21 Research Sources
  • List of Tables
    • Table 1 Sales of Analgesics by Category: Value 2005-2010
    • Table 2 Sales of Analgesics by Category: % Value Growth 2005-2010
    • Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
    • Table 4 Analgesics Company Shares by Value 2006-2010
    • Table 5 Analgesics Brand Shares by Value 2007-2010
    • Table 6 Forecast Sales of Analgesics by Category: Value 2010-2015
    • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015
    • Table 8 Consumer Expenditure on Health Goods and Medical Services 2005-2010
    • Table 9 Life Expectancy at Birth 2005-2010
    • Table 10 Sales of Consumer Health by Category: Value 2005-2010
    • Table 11 Sales of Consumer Health by Category: % Value Growth 2005-2010
    • Table 12 Sales of Consumer Health by Region: Value 2005-2010
    • Table 13 Sales of Consumer Health by Region: % Value Growth 2005-2010
    • Table 14 Consumer Health Company Shares by Value 2006-2010
    • Table 15 Consumer Health Brand Shares by Value 2007-2010
    • Table 16 Penetration of Private Label by Category 2005-2010
    • Table 17 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
    • Table 18 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
    • Table 19 Forecast Sales of Consumer Health by Category: Value 2010-2015
    • Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015